The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Tertiary lymphoid structures, drivers of the anti‐tumor responses in human cancers
Abstract
Summary: The characterization of the microenvironment of human tumors led to the description of tertiary lymphoid structures (TLS) characterized by mature dendritic cells in a T‐cell zone adjacent to B‐cell follicle including a germinal center.TLS represent sites of lymphoid neogenesis that develop in most solid cancers. Analysis of the current literature shows that the TLS presence is associated with a favorable clinical outcome for cancer patients, regardless of the approach used to quantify TLS and the stage of the disease. Using several approaches that combine immunohistochemistry, gene expression assays, and flow cytometry on large series of lung tumors, our work demonstrated that TLS are important sites for the initiation and/or maintenance of the local and systemic T‐ and B‐cell responses against tumors. Surrounded by high endothelial venules, they represent a privileged area for the recruitment of lymphocytes into tumors and generation of central‐memory T and B cells that circulate and limit cancer progression.TLS can be considered as a novel biomarker to stratify the overall survival risk of untreated cancer patients and as a marker of efficient immunotherapies. The induction and manipulation of cancer‐associated TLS using drug agonists and/or biotherapies should open new avenues to treat cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Self-citationInvolvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Self-citationSpatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,422
Self-citationCancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135 · cited 1×
“Thus, high densities of CD8 T cells and CD45RO memory T cells correlate with a favorable prognosis, when located at both the IM and CT (2, 3).”
BackgroundSelf-citationCancer immunotherapy via dendritic cells
Palucka, K., & Banchereau, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3258 · Cited by 2,049
RANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478
Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors
Altman, D. G., Lausen, B., Sauerbrei, W., & Schumacher, M. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.11.829 · Cited by 1,143
CD4+ follicular helper T cell infiltration predicts breast cancer survival
Gu-Trantien, C., Loi, S., Garaud, S., Equeter, C., Libin, M., de Wind, A., Ravoet, M., Le Buanec, H., Sibille, C., Manfouo-Foutsop, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67428 · Cited by 1,070
Dieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,031
Self-citationGermain, C., Gnjatic, S., Tamzalit, F., Knockaert, S., Remark, R., Goc, J., Lepelley, A., Becht, E., Katsahian, S., Bizouard, G., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1611oc · Cited by 833
Self-citationRole of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity
Moyron-Quiroz, J. E., Rangel-Moreno, J., Kusser, K., Hartson, L., Sprague, F., Goodrich, S., Woodland, D. L., Lund, F. E., & Randall, T. D. (2004) · Nature Medicine · doi:10.1038/nm1091 · Cited by 821
Zotos, D., Coquet, J. M., Zhang, Y., Light, A., D'Costa, K., Kallies, A., Corcoran, L. M., Godfrey, D. I., Toellner, K.-M., Smyth, M. J., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091777 · Cited by 777
Gobert, M., Treilleux, I., Bendriss-Vermare, N., Bachelot, T., Goddard-Leon, S., Arfi, V., Biota, C., Doffin, A. C., Durand, I., Olive, D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2360 · Cited by 758
A Fundamental Role for Interleukin-21 in the Generation of T Follicular Helper Cells
Vogelzang, A., McGuire, H. M., Yu, D., Sprent, J., Mackay, C. R., & King, C. (2008) · Immunity · doi:10.1016/j.immuni.2008.06.001 · Cited by 739
HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes
Girard, J.-P., Moussion, C., & Förster, R. (2012) · Nature Reviews Immunology · doi:10.1038/nri3298 · Cited by 713
Ectopic lymphoid-like structures in infection, cancer and autoimmunity
Pitzalis, C., Jones, G. W., Bombardieri, M., & Jones, S. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3700 · Cited by 698
Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
Lacey, D. L., Boyle, W. J., Simonet, W. S., Kostenuik, P. J., Dougall, W. C., Sullivan, J. K., Martin, J. S., & Dansey, R. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3705 · Cited by 694
Goc, J., Germain, C., Vo-Bourgais, T. K. D., Lupo, A., Klein, C., Knockaert, S., de Chaisemartin, L., Ouakrim, H., Becht, E., Alifano, M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1342 · Cited by 677
Self-citationICOS is essential for effective T-helper-cell responses
Tafuri, A., Shahinian, A., Bladt, F., Yoshinaga, S. K., Jordana, M., Wakeham, A., Boucher, L.-M., Bouchard, D., Chan, V. S. F., Duncan, G., et al. (2001) · Nature · doi:10.1038/35051113 · Cited by 675
for the Multiple Sclerosis Genetics Group, Gregory, S. G., Schmidt, S., Seth, P., Oksenberg, J. R., Hart, J., Prokop, A., Caillier, S. J., Ban, M., Goris, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2103 · Cited by 657
Nakano, O., Sato, M., Naito, Y., Suzuki, K., Orikasa, S., Aizawa, M., Suzuki, Y., Shintaku, I., Nagura, H., & Ohtani, H. (2001) · PubMed · Cited by 639
Tertiary lymphoid structures in cancer and beyond
Dieu-Nosjean, M.-C., Goc, J., Giraldo, N. A., Sautès-Fridman, C., & Fridman, W. H. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.09.006 · Cited by 617
Self-citationNew insights into the development of lymphoid tissues
van de Pavert, S. A., & Mebius, R. E. (2010) · Nature Reviews Immunology · doi:10.1038/nri2832 · Cited by 604
Menetrier-Caux, C., Montmain, G., Dieu, M. C., Bain, C., Favrot, M. C., Caux, C., & Blay, J. Y. (1998) · Blood · doi:10.1182/blood.v92.12.4778 · Cited by 590
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
Lutz, E. R., Wu, A. A., Bigelow, E., Sharma, R., Mo, G., Soares, K., Solt, S., Dorman, A., Wamwea, A., Yager, A., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0027 · Cited by 550
Joshi, N. S., Akama-Garren, E. H., Lu, Y., Lee, D.-Y., Chang, G. P., Li, A., DuPage, M., Tammela, T., Kerper, N. R., Farago, A. F., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.006 · Cited by 520
Martinet, L., Garrido, I., Filleron, T., Le Guellec, S., Bellard, E., Fournie, J.-J., Rochaix, P., & Girard, J.-P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0431 · Cited by 516
Giraldo, N. A., Becht, E., Pagès, F., Skliris, G., Verkarre, V., Vano, Y., Mejean, A., Saint-Aubert, N., Lacroix, L., Natario, I., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2926 · Cited by 507
Self-citationBaekkevold, E. S., Roussigné, M., Yamanaka, T., Johansen, F.-E., Jahnsen, F. L., Amalric, F., Brandtzaeg, P., Erard, M., Haraldsen, G., & Girard, J.-P. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63631-0 · Cited by 474
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
Uzzan, B., Nicolas, P., Cucherat, M., & Perret, G.-Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1957 · Cited by 468
Coppola, D., Nebozhyn, M., Khalil, F., Dai, H., Yeatman, T., Loboda, A., & Mulé, J. J. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.03.007 · Cited by 434
Finkin, S., Yuan, D., Stein, I., Taniguchi, K., Weber, A., Unger, K., Browning, J. L., Goossens, N., Nakagawa, S., Gunasekaran, G., et al. (2015) · Nature Immunology · doi:10.1038/ni.3290 · Cited by 433
Messina, J. L., Fenstermacher, D. A., Eschrich, S., Qu, X., Berglund, A. E., Lloyd, M. C., Schell, M. J., Sondak, V. K., Weber, J. S., & Mulé, J. J. (2012) · Scientific Reports · doi:10.1038/srep00765 · Cited by 426
Des Guetz, G., Uzzan, B., Nicolas, P., Cucherat, M., Morere, J.-F., Benamouzig, R., Breau, J.-L., & Perret, G.-Y. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603176 · Cited by 406
de Saint-Vis, B., Vincent, J., Vandenabeele, S., Vanbervliet, B., Pin, J.-J., Aït-Yahia, S., Patel, S., Mattei, M.-G., Banchereau, J., Zurawski, S., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80615-9 · Cited by 399
Di Caro, G., Bergomas, F., Grizzi, F., Doni, A., Bianchi, P., Malesci, A., Laghi, L., Allavena, P., Mantovani, A., & Marchesi, F. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2590 · Cited by 386
In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor
Boissonnas, A., Fetler, L., Zeelenberg, I. S., Hugues, S., & Amigorena, S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061890 · Cited by 377
GeurtsvanKessel, C. H., Willart, M. A. M., Bergen, I. M., van Rijt, L. S., Muskens, F., Elewaut, D., Osterhaus, A. D. M. E., Hendriks, R., Rimmelzwaan, G. F., & Lambrecht, B. N. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090410 · Cited by 376
Remark, R., Alifano, M., Cremer, I., Lupo, A., Dieu-Nosjean, M.-C., Riquet, M., Crozet, L., Ouakrim, H., Goc, J., Cazes, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3847 · Cited by 375
Self-citationHiraoka, N., Ino, Y., Yamazaki-Itoh, R., Kanai, Y., Kosuge, T., & Shimada, K. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.145 · Cited by 367
de Chaisemartin, L., Goc, J., Damotte, D., Validire, P., Magdeleinat, P., Alifano, M., Cremer, I., Fridman, W.-H., Sautès-Fridman, C., & Dieu-Nosjean, M.-C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0952 · Cited by 338
Self-citationFrom mice to humans: developments in cancer immunoediting
Teng, M. W. L., Galon, J., Fridman, W.-H., & Smyth, M. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80004 · Cited by 337
Self-citationBeuselinck, B., Job, S., Becht, E., Karadimou, A., Verkarre, V., Couchy, G., Giraldo, N., Rioux-Leclercq, N., Molinié, V., Sibony, M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1128 · Cited by 315
Self-citationConrad, C., Gregorio, J., Wang, Y.-H., Ito, T., Meller, S., Hanabuchi, S., Anderson, S., Atkinson, N., Ramirez, P. T., Liu, Y.-J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2271 · Cited by 314
van de Pavert, S. A., Olivier, B. J., Goverse, G., Vondenhoff, M. F., Greuter, M., Beke, P., Kusser, K., Höpken, U. E., Lipp, M., Niederreither, K., et al. (2009) · Nature Immunology · doi:10.1038/ni.1789 · Cited by 312
Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules
Moussion, C., & Girard, J.-P. (2011) · Nature · doi:10.1038/nature10540 · Cited by 311
Halle, S., Dujardin, H. C., Bakocevic, N., Fleige, H., Danzer, H., Willenzon, S., Suezer, Y., Hämmerling, G., Garbi, N., Sutter, G., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091472 · Cited by 295
Ladányi, A., Kiss, J., Somlai, B., Gilde, K., Fejős, Z., Mohos, A., Gaudi, I., & Tímár, J. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-007-0286-3 · Cited by 287
Lymphoid neogenesis in chronic rejection: Evidence for a local humoral alloimmune response
Thaunat, O., Field, A.-C., Dai, J., Louedec, L., Patey, N., Bloch, M.-F., Mandet, C., Belair, M.-F., Bruneval, P., Meilhac, O., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507223102 · Cited by 261
Ruddle, N. H., & Akirav, E. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804324 · Cited by 259
Maldonado, L., Teague, J. E., Morrow, M. P., Jotova, I., Wu, T. C., Wang, C., Desmarais, C., Boyer, J. D., Tycko, B., Robins, H. S., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007323 · Cited by 255
Interleukin-21 inhibits dendritic cell activation and maturation
Brandt, K., Bulfone-Paus, S., Foster, D. C., & Rückert, R. (2003) · Blood · doi:10.1182/blood-2003-03-0669 · Cited by 245
Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS)
Simpson, T. R., Quezada, S. A., & Allison, J. P. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.001 · Cited by 233
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells
Végran, F., Berger, H., Boidot, R., Mignot, G., Bruchard, M., Dosset, M., Chalmin, F., Rébé, C., Dérangère, V., Ryffel, B., et al. (2014) · Nature Immunology · doi:10.1038/ni.2925 · Cited by 228
Hennequin, A., Derangère, V., Boidot, R., Apetoh, L., Vincent, J., Orry, D., Fraisse, J., Causeret, S., Martin, F., Arnould, L., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1054598 · Cited by 226
Minimal Recruitment and Activation of Dendritic Cells Within Renal Cell Carcinoma
Troy, A. J., Summers, K. L., Davidson, P. J. T., Atkinson, C. H., & Hart, D. N. J. (1999) · The Journal of Urology · doi:10.1097/00005392-199905000-00138 · Cited by 220
Meier, D., Bornmann, C., Chappaz, S., Schmutz, S., Otten, L. A., Ceredig, R., Acha-Orbea, H., & Finke, D. (2007) · Immunity · doi:10.1016/j.immuni.2007.04.009 · Cited by 219
Faget, J., Bendriss-Vermare, N., Gobert, M., Durand, I., Olive, D., Biota, C., Bachelot, T., Treilleux, I., Goddard-Leon, S., Lavergne, E., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2409 · Cited by 217
Vassileva, G., Soto, H., Zlotnik, A., Nakano, H., Kakiuchi, T., Hedrick, J. A., & Lira, S. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.8.1183 · Cited by 216
Leukocyte migration in the interstitial space of non-lymphoid organs
Weninger, W., Biro, M., & Jain, R. (2014) · Nature Reviews Immunology · doi:10.1038/nri3641 · Cited by 213
Mak, T. W., Shahinian, A., Yoshinaga, S. K., Wakeham, A., Boucher, L.-M., Pintilie, M., Duncan, G., Gajewska, B. U., Gronski, M., Eriksson, U., et al. (2003) · Nature Immunology · doi:10.1038/ni947 · Cited by 209
Chen, S.-C., Vassileva, G., Kinsley, D., Holzmann, S., Manfra, D., Wiekowski, M. T., Romani, N., & Lira, S. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1001 · Cited by 201
Martinet, L., Le Guellec, S., Filleron, T., Lamant, L., Meyer, N., Rochaix, P., Garrido, I., & Girard, J.-P. (2012) · OncoImmunology · doi:10.4161/onci.20492 · Cited by 193
Fan, L., Reilly, C. R., Luo, Y., Dorf, M. E., & Lo, D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.3955 · Cited by 183
Rangel-Moreno, J., Moyron-Quiroz, J. E., Hartson, L., Kusser, K., & Randall, T. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700591104 · Cited by 182
The immune contexture of primary and metastatic human tumours
Giraldo, N. A., Becht, É., Remark, R., Damotte, D., Sautès‐Fridman, C., & Fridman, W. H. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.001 · Cited by 174
Self-citationManzo, A., Bombardieri, M., Humby, F., & Pitzalis, C. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00861.x · Cited by 171
Clement, M., Guedj, K., Andreata, F., Morvan, M., Bey, L., Khallou-Laschet, J., Gaston, A.-T., Delbosc, S., Alsac, J.-M., Bruneval, P., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.010988 · Cited by 165
Lee, H. J., Park, I. A., Song, I. H., Shin, S.-J., Kim, J. Y., Yu, J. H., & Gong, G. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-203089 · Cited by 162
The role of IL-21 in immunity and cancer
Davis, M. R., Zhu, Z., Hansen, D. M., Bai, Q., & Fang, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.12.047 · Cited by 154
Melanoma Cells Express ICOS Ligand to Promote the Activation and Expansion of T-Regulatory Cells
Martín‐Orozco, N., Li, Y., Wang, Y., Liu, S., Hwu, P., Liu, Y., Dong, C., & Radvanyi, L. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1379 · Cited by 150
Lee, L., Logronio, K. A., Tu, G. H., Zhai, W., Ni, I., Mei, L., Dilley, J., Yu, J., Rajpal, A., Brown, C. N., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203795109 · Cited by 138
Characteristics and significance of colorectal cancer associated lymphoid reaction
Väyrynen, J. P., Väyrynen, S. A., Klintrup, K., Mäkelä, J. T., Herzig, K., Karttunen, T. J., Tuomisto, A., & Mäkinen, M. J. (2013) · International Journal of Cancer · doi:10.1002/ijc.28533 · Cited by 133
Perna, S. K., Pagliara, D., Mahendravada, A., Liu, H., Brenner, M. K., Savoldo, B., & Dotti, G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1016 · Cited by 131
IL-21: a novel IL-2–family lymphokine that modulates B, T, and natural killer cell responses
Habib, T., Nelson, A., & Kaushansky, K. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.039 · Cited by 127
Zhu, W., Germain, C., Liu, Z., Sebastian, Y., Devi-Marulkar, P., Knockaert, S., Brohawn, P. Z., Lehmann, K. P., Damotte, D., Validire, P., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1051922 · Cited by 125
Self-citationTargeting the Lymphotoxin-β Receptor with Agonist Antibodies as a Potential Cancer Therapy
Lukashev, M., LePage, D., Wilson, C. A., Bailly, V., Garber, E. A., Lukashin, A., Ngam-ek, A., Zeng, W., Allaire, N., Perrin, S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0217 · Cited by 125
CXCL13 antibody for the treatment of autoimmune disorders
Klimatcheva, E., Pandina, T., Reilly, C. A., Torno, S., Bußler, H., Scrivens, M., Jonason, A. S., Mallow, C. L., Doherty, M., Paris, M. J., et al. (2015) · BMC Immunology · doi:10.1186/s12865-015-0068-1 · Cited by 124
Wirsing, A. M., Rikardsen, O., Steigen, S. E., Uhlin‐Hansen, L., & Hadler‐Olsen, E. (2014) · BMC Clinical Pathology · doi:10.1186/1472-6890-14-38 · Cited by 124
Meshcheryakova, A., Tamandl, D., Bajna, E., Stift, J., Mittlboeck, M., Svoboda, M., Heiden, D., Stremitzer, S., Jensen‐Jarolim, E., Gruenberger, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099008 · Cited by 118
Tumor microenvironment is multifaceted
Sautès‐Fridman, C., Cherfils‐Vicini, J., Damotte, D., Fisson, S., Fridman, W. H., Cremer, I., & Dieu‐Nosjean, M. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9279-y · Cited by 118
Self-citationDing, Y., Li, J., Yang, P., Luo, B., Wu, Q., Zajac, A. J., Wildner, O., Hsu, H., & Mountz, J. D. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38735 · Cited by 117
Wolf, M. J., Seleznik, G. M., Zeller, N., & Heikenwälder, M. F. (2010) · Oncogene · doi:10.1038/onc.2010.260 · Cited by 116
RANK-Fc: A therapeutic antagonist for RANK-L in myeloma
Sordillo, E. M., & Pearse, R. N. (2003) · Cancer · doi:10.1002/cncr.11134 · Cited by 109
Targeting Costimulatory Molecules to Improve Antitumor Immunity
Capece, D., Verzella, D., Fischietti, M., Zazzeroni, F., & Alesse, E. (2012) · BioMed Research International · doi:10.1155/2012/926321 · Cited by 109
Oldham, K. A., Parsonage, G., Bhatt, R. I., Wallace, D. M. A., Deshmukh, N., Chaudhri, S., Adams, D. H., & Lee, S. P. (2012) · European Urology · doi:10.1016/j.eururo.2011.10.035 · Cited by 104
Dønnem, T., Al‐Saad, S., Al-Shibli, K. I., Delghandi, M. P., Persson, M., Nilsen, M. N., Busund, L., & Bremnes, R. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0414 · Cited by 102
Kim, J. Y., Lim, S., Kim, G., Yun, H. J., Ahn, S. G., & Choi, H. S. (2014) · Oncogene · doi:10.1038/onc.2014.418 · Cited by 96
Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses
Monteleone, G., Pallone, F., & MacDonald, T. T. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.02.008 · Cited by 95
Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma
Hotta, K., Sho, M., Fujimoto, K., Shimada, K., Yamato, I., Anai, S., Konishi, N., Hirao, Y., Nonomura, K., & Nakajima, Y. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.368 · Cited by 92
RANK/RANKL/OPG role in distraction osteogenesis
Pérez‐Sayáns, M., Martín, J. M. S., Barros, F., Rey, J. M. G., & García, A. G. (2010) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2009.10.042 · Cited by 91
Attig, S., Hennenlotter, J., Pawelec, G., Klein, G., Koch, S. D., Pircher, H., Feyerabend, S., Wernet, D., Stenzl, A., Rammensee, H., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0852 · Cited by 90
HIGH EXPRESSION OF CHEMOKINE GENE AS A FAVORABLE PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA
Kondo, T., ITO, F., Nakazawa, H., Horita, S., Osaka, Y., & Toma, H. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000127726.25609.87 · Cited by 89
Busse, M., Krech, M., Meyer‐Bahlburg, A., Hennig, C., & Hansen, G. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103581 · Cited by 89
Heninger, A., Theil, A., Wilhelm, C., Petzold, C., Huebel, N., Kretschmer, K., Bonifacio, E. E., & Monti, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201286 · Cited by 89
Seo, Y. B., Im, S. J., Namkoong, H., Kim, S. W., Choi, Y. W., Kang, M. C., Lim, H. S., Jin, H., Yang, S. H., Cho, M. L., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00534-14 · Cited by 86
Effects of CXCL 13 inhibition on lymphoid follicles in models of autoimmune disease
Finch, D. K., Ettinger, R., Karnell, J. L., Herbst, R., & Sleeman, M. A. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12063 · Cited by 83
Suyama, T., Furuya, M., Nishiyama, M., Kasuya, Y., Kimura, S., Ichikawa, T., Ueda, T., Nikaido, T., Itô, H., & Ishikura, H. (2004) · Cancer · doi:10.1002/cncr.20747 · Cited by 80
The IL-7 Signaling Pathway Regulates Lymph Node Development Independent of Peripheral Lymphocytes
Chappaz, S., & Finke, D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901647 · Cited by 79
Wang, Q. J., Hanada, K., Robbins, P. F., Li, Y. F., & Yang, J. C.-H. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0588 · Cited by 75
Sharpe, K., Stewart, G. D., Mackay, A. G., Neste, C. V., Rofe, C., Berney, D. M., Kayani, I. A., Bex, A., Wan, E., O’Mahony, F. C., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1631 · Cited by 73
Polimeno, M., Napolitano, M., Costantini, S., Portella, L., Esposito, A., Capone, F., Guerriero, E., Trotta, A. M., Zanotta, S., Pucci, L., et al. (2013) · British Journal of Urology · doi:10.1111/bju.12068 · Cited by 68
Survival in rectal cancer is predicted by T cell infiltration of tumour-associated lymphoid nodules
McMullen, T. P. W., Lai, R. L., Dabbagh, L., Wallace, T., & de Gara, C. J. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04147.x · Cited by 66
A stepwise breakdown of B-cell tolerance occurs within renal allografts during chronic rejection
Thaunat, O., Graff‐Dubois, S., Fabien, N., Duthey, A., Attuil-Audenis, V., Nicoletti, A., Patey, N., & Morélon, E. (2011) · Kidney International · doi:10.1038/ki.2011.317 · Cited by 64
Expression and function of the chemokine receptor CCR7 in thyroid carcinomas
Sancho, M., Vieira, J. M., Casalou, C., Mesquita, M., Pereira, T., Cavaco, B. M., Dias, S., & Leite, V. A. P. H. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06688 · Cited by 62
Behr, D. S., Peitsch, W. K., Hametner, C., Lasitschka, F., Houben, R., Schönhaar, K., Michel, J., Dollt, C., Goebeler, M., Marx, A., et al. (2014) · Europe PMC (PubMed Central) · Cited by 59
The immune response in cancer: from immunology to pathology to immunotherapy
Giraldo, N. A., Becht, É., Vano, Y. A., Sautès‐Fridman, C., & Fridman, W. H. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1787-7 · Cited by 59
Self-citationInterleukin-7 Influences FOXP3+CD4+ Regulatory T Cells Peripheral Homeostasis
Simonetta, F., Gestermann, N., Martinet, K. Z., Boniotto, M., Tissières, P., Seddon, B. P., & Bourgeois, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036596 · Cited by 56
Lin, Y., Sharma, S. P., & John, M. A. S. (2014) · Cancers · doi:10.3390/cancers6021098 · Cited by 56
Immune Responses Elicited in Tertiary Lymphoid Tissues Display Distinctive Features
Thaunat, O., Graff‐Dubois, S., Brouard, S., Gautreau, C., Varthaman, A., Fabien, N., Field, A.-C., Louedec, L., Dai, J., Joly, E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011398 · Cited by 53
Figel, A.-M., Brech, D., Prinz, P. U., Lettenmeyer, U. K., Eckl, J., Turqueti‐Neves, A., Mysliwietz, J., Anz, D., Rieth, N., Muenchmeier, N., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.011 · Cited by 53
Meta-Analysis Identifies NF-κB as a Therapeutic Target in Renal Cancer
Peri, S., Devarajan, K., Yang, D., Knudson, A. G., & Balachandran, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076746 · Cited by 52
Younas, M., Hüe, S., Lacabaratz, C., Guguin, A., Wiedemann, A., Surénaud, M., Beq, S., Croughs, T., Lelièvre, J., & Lévy, Y. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203547 · Cited by 46
Gigante, M., Blasi, A., Loverre, A., et al. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.09.015 · Cited by 44
Somovilla-Crespo, B., Alfonso-Pérez, M., Cuesta‐Mateos, C., Dios, C. C.-D., Beltrán, A. E., Terrón, F., Pérez‐Villar, J. J., Gamallo-Amat, C., Pérez-Chacón, G., Fernández‐Ruiz, E., et al. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-89 · Cited by 44
Liang, C., Zhong, C., Sun, R., Liu, B., Huang, C., Qin, J., Zhou, S. Y., Shan, J., Liu, Y., & Ye, S. (2007) · Journal of Virology · doi:10.1128/jvi.00208-07 · Cited by 41
The Association of CXCR3 and Renal Cell Carcinoma Metastasis
Utsumi, T., Suyama, T., Imamura, Y., Fuse, M., Sakamoto, S., Nihei, N., Ueda, T., Suzuki, H., Seki, N., & Ichikawa, T. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.01.100 · Cited by 40
Romero, J. M., Aptsiauri, N., Vazquez, F., Cozar, J. M., Cantón, J., Cabrera, T., Tallada, M., Garrido, F., & Ruiz‐Cabello, F. (2006) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00673.x · Cited by 39
Cabillic, F., Bouet-Toussaint, F., Toutirais, O., Rioux-Leclercq, N. C., Fergelot, P., Pintière, C. T. D. L., Genetet, N., Patard, J. J., & Quémener, V. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03212.x · Cited by 38
Tan, W., Hildebrandt, M. A. T., Pu, X., Huang, M., Lin, J. M., Matin, S. F., Tamboli, P., Wood, C. G., & Wu, X. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.06.049 · Cited by 37
Falkensammer, C. E., Jöhrer, K., Gander, H., Ramoner, R. E., Putz, T., Rahm, A., Greil, R., Bartsch, G. H., & Thurnher, M. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0122-1 · Cited by 35
Pilkington, K. R., Clark‐Lewis, I., & McColl, S. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405808200 · Cited by 33
Manifestation of Spontaneous and Early Autoimmune Gastritis in CCR7-Deficient Mice
Winter, S., Rehm, A., Wichner, K., Scheel, T., Batra, A., Siegmund, B., Berek, C., Lipp, M., & Höpken, U. E. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.04.012 · Cited by 25
Schüler, Y., Lee‐Thedieck, C., Geiger, K., Kaiser, T., Ino, Y., Aicher, W. K., & Klein, G. (2011) · International Journal of Cancer · doi:10.1002/ijc.25981 · Cited by 24
Martinet, L., & Girard, J. (2013) · OncoImmunology · doi:10.4161/onci.26470 · Cited by 24
Igarashi, T., Murakami, S., Takahashi, H., Matsuzaki, O., & Shimazaki, J. (1992) · European Urology · doi:10.1159/000474780 · Cited by 21
Simonetta, F., Gestermann, N., Bloquet, S., & Bourgeois, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113314 · Cited by 17
Rational Design of Interleukin-21 Antagonist through Selective Elimination of the γC Binding Epitope
Kang, L., Bondensgaard, K., Li, T., Hartmann, R., & Hjorth, S. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.101444 · Cited by 15
Determination of Angiogenic Factors in Serum by Protein Array in Patients with Renal Cell Carcinoma
Lukešová, Š., Kopecký, O., Vroblova, V., Hlávková, D., Andrýs, C., Morávek, P., & Čermáková, E. (2008) · Folia Biologica · doi:10.14712/fb2008054040134 · Cited by 9
Cited by
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
The immune contexture in cancer prognosis and treatment
Fridman, W. H., Zitvogel, L., Sautès–Fridman, C., & Kroemer, G. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.101 · Cited by 2,263
Self-citationTertiary lymphoid structures in the era of cancer immunotherapy
Sautès-Fridman, C., Petitprez, F., Calderaro, J., & Fridman, W. H. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0144-6 · Cited by 1,884
CD8+ T cell states in human cancer: insights from single-cell analysis
van der Leun, A. M., Thommen, D. S., & Schumacher, T. N. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0235-4 · Cited by 1,472
Tertiary lymphoid structures in cancer
Schumacher, T. N., & Thommen, D. S. (2022) · Science · doi:10.1126/science.abf9419 · Cited by 1,142
Metadata
- Authors
- Dieu‐Nosjean, M., Giraldo, N. A., Kaplon, H., Germain, C., Fridman, W. H., & Sautès‐Fridman, C.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2016-04-18
- Volume
- 271
- Issue
- 1
- Pages
- 260-275
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2339442385
- Cited by
- 417
- References
- 132
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.